Frequently searched
↑ ↓ to move · Enter to open · Esc to closeSynonyms and typos are matched
Trial site
Active, not recruiting
A Study to Evaluate the Safety and Efficacy of Nizubaglustat (AZ-3102) in Patients With GM2 Gangliosidosis or Niemann-Pick Type C Disease
NCT07399704· Phase 2· Azafaros B.V.· Source
Site data: ClinicalTrials.govUpdated 12 Nov 2026
Report an error